Lobbying disclosures · Lobbying report
MRK: third_quarter 2026 lobbying report
Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 951A, and 250.
Follow MRK- Became public
- Oct 16, 2026, 1:13 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 4:17 AM EST
Why this is connected
Exact legal-name match: Merck & Co., Inc. (https://www.sec.gov/Archives/edgar/data/310158/).
Reported lobbying amounts
Income: $10,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/9202fa5d-0840-4861-b345-31ce96dc70f6/","filing_uuid":"9202fa5d-0840-4861-b345-31ce96dc70f6","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/9202fa5d-0840-4861-b345-31ce96dc70f6/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zach Price","dt_posted":"2026-10-16T13:13:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"505 9th Street NW","registrant_address_2":"Suite 830","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":294930,"url":"https://lda.gov/api/v1/registrants/294930/","house_registrant_id":37434,"name":"THE WASHINGTON TAX & PUBLIC POLICY GROUP","description":"​Legislative and regulatory consulting.","address_1":"505 9th Street NW","address_2":"Suite 830","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREGORY NICKERSON","contact_telephone":"+1 202-534-4949","dt_updated":"2026-10-20T14:56:42.462084-04:00"},"client":{"id":75350,"url":"https://lda.gov/api/v1/clients/75350/","client_id":75350,"name":"MERCK & CO., INC","general_description":"Pharmaceuticals.","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-09-01"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 951A, and 250.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":38177,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"NICKERSON","suffix":null,"suffix_display":null},"covered_position":"Tax Counsel Committee on Ways and Means; Staff Director Ways and Means Select Revenue Measures Subcommittee","new":false},{"lobbyist":{"id":149073,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"MAX","last_name":"PEDROTTI","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of Staff to Rep. Carol Miller","new":false},{"lobbyist":{"id":69617,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":"AUSTIN","last_name":"PRICE","suffix":null,"suffix_display":null},"covered_position":"Staff assistant to Senator Coats.","new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in MRK
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 2, 2026 · disclosed Nov 5, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
Sold (partial) Merck & Co. MRK
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 7, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 9, 2026$15K–$50K
Rep. Maria Elvira Salazar (R-FL-27)
$15K–$50K · Traded Aug 19, 2026 · disclosed Sep 9, 2026
- Sep 9, 2026$15K–$50K
Rep. Maria Elvira Salazar (R-FL-27)
$15K–$50K · Traded Aug 19, 2026 · disclosed Sep 9, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 30, 2026$1K–$15K
Rep. Keith Self (R-TX-3)
$1K–$15K · Traded Jan 10, 2025 · disclosed Jun 30, 2026 · filed 536 days later
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.